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tions are always at hand. The subject of 
thalassaemia is of course a good prototype: for 
years haematologists have had to adopt more and 
more advanced biochemical methods to work out 
the pathophysiology of these syndromes until, with 
the cloning of the globin genes, molecular biology 
took over and has ably exploited the study of a 
multitude of different patients to understand how 
point mutations and deletions can affect the rate of 
cy and ,13 globin synthesis. Arthur Bank had the dif- 
ficult task of writing yet another synopsis on this 
topic and he has done so succinctly, but with due 
attention to new developments in prenatal 
diagnosis. The following chapter is a comprehen- 
sive review on ferritin by Allan Jacobs, who has 
personally contributed so much to establishing fer- 
ritin assays as a major parameter in assessing the 
iron status of patients with a variety of 
haematological and non-haematological disorders. 
Ferritin is a protein with a unique chemistry, and 
the qualification in the title of ‘interim review’ 
refers perhaps to the fact that the next review on 
the subject will cover the structure of cloned fer- 
ritin genes, which this chapter has inevitably 
missed because of its timing. Next Schwartz, Chin 
and Lubin discuss the red cell membrane. Most 
reviews on this topic have looked at proteins, 
whereas this chapter deals with the phospholipid 
component, illustrating their asymmetrical dis- 
tribution across the membrane and bringing up 
some interesting implications with respect to the 
pathophysiology of certain thrombophilic states. 
Margaret and Simon Karpatkin have next sum- 
marized experimental work, carried out mostly by 
themselves in the rabbit and in the mouse, on 
humoral factors which control the level of some 
vitamin K-dependent coagulation proteins. On a 
personal note, I enjoyed reading the last chapter 
on transferrin (TRF) receptors, by Ugo Testa, with 
whom we had written the first chapter in volume 1 
of this series. Work on TRF receptors started, like 
that on ferritin, as an aspect of the investigation of 
iron metabolism. It has now developed as an im- 
portant cell marker which undergoes interesting 
changes during the maturation of haemopoietic 
cells. This work is likely to develop further now 
that the TRF receptor gene has been cloned. 
This book is good value for both haematologists 
and biochemists: even better, for anyone interested 
in these topics, regardless of their disciplinary 
label. We can congratulate Sergio Piomelli and 
Stanley Yachnin once again for persuading busy 
investigators to devote time to writing these 
reviews. 
L . Luzzatto 
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This book contains contributions on radioligand 
binding assay, monoclonal antibody production 
and nuclear magnetic resonance methods. 
Triggle and Janis provide a succinct but very 
detailed summary of the large body of literature up 
to 1983 on binding studies of calcium channel an- 
tagonists, mainly nitrendipine. This information 
complements the conclusions already drawn from 
functional studies and structure-activity relation- 
ships (e.g., more than one class and site of binding 
of antagonists to the calcium channel), and thus 
emphasises the usefulness of this experimental ap- 
proach. The authors are also careful to point out 
some of the more important discrepancies between 
binding studies and the ‘real’ pharmacology. 
However, although this essay will be useful for the 
calcium channel enthusiast, it does not give any 
practical details of the method and cannot be 
regarded as sufficiently explanatory to be entirely 
relevant to the title of the book. A beginner cer- 
tainly could not hope to get much idea of how 
radioligand assays are performed (although 
Triggle and Janis do point out some important 
technical considerations), and would have to turn 
elsewhere for proper guidance. 
This major reservation is not applicable to the 
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other Chapters. James Morgan’s extended review 
on monoclonal antibody production is an excep- 
tionally useful guide to this technique. It achieves 
its aim of demystification, and concentrates on a 
step-by-step description of the methods preferred 
by the author. You can judge the detail from the 
following extract: “ . . . sufficient macrophages are 
required to seed twelve 24-well tissue culture 
clusters (e.g. Costar, cat. no.3524) or five 96-well 
microtitre culture trays (e.g. Falcon, no.3042). . 
since on average a young adult BALB/c mouse 
yields between 1.5 and 3.0 x lo6 peritoneal 
macrophages, it may be calculated that one must 
use approximately lo- 15 mice per fusion.. . “_ The 
author also draws attention to the most important 
problem of all, namely whether to choose 
hybridoma ‘or conventional antibody techniques. 
The final essay by C.E. Brown on NMR in 
neurobiology presents a simplified description of 
NMR theory and how the method can be used to 
infer detail of chemical structure and interactions 
between molecules, and then proceeds to a series of 
detailed examples drawn largely from the author’s 
own studies on carnosine. For example, he shows 
how NMR can be used to study the interaction of 
carnosine with copper and serum albumin, and 
ligand binding (in this case of carnosine with nasal 
olfactory epithelium membranes). This discussion 
amply illustrates the strengths and limitations of 
NMR in the pharmacological context. 
Bearing in mind my reservations about the 
ligand binding assay chapter, this well produced 
little book can be warmly recommended. It should 
be of considerable use in prompting the novice to 
consider taking up new methods of analysis. 
Robin Hoult 
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This volume represents the proceedings of the 4th 
Philadelphia Symposium on Aging held in early 
April, 1983, and as such is a slightly aging volume 
itself. It is divided into 4 main sections: (I) Central 
nervous system receptors and endocrine function, 
(II) Alteration in sex hormones and insulin activity 
with age, (III) Endogenous substances influencing 
cellular aging, and (IV) Abstracts. 
The initial overview by G. Litwack at the start of 
the volume is a summary and discussion of the role 
of receptors in hormone activity - it is unfor- 
tunately not an overview in the sense of setting the 
scene for the other articles in the volume. Indeed, 
the bulk of the volume consists of a (too) wide mix 
of topics dealt with in a variety of ways, from 
original research findings and abstracts to full- 
blown reviews. This variety is accentuated by the 
various formats, typefaces and styles of presenta- 
tion. The majority of the ‘whole body’ informa- 
tion presented is on the aging rat, and there is 
relatively little on man. S.G. Korenman and S. 
Stan&, however, present a concise summary of the 
‘Male reproductive system and aging’ in humans. 
J.D. Tobin also presents a short discussion paper 
on the problems of defining and diagnosing 
diabetes in aging humans. The volume is weighted 
towards papers dealing with aging cells in culture 
and 6 of the 13 abstracts and one main article are 
from the laboratories of V-3. Cristofalo. 
Who should buy this volume? Libraries with 
money to spare and any dedicated bibliophile who 
could not bear to be missing a volume of Modern 
Aging Research. 
S.R. Milligan 
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